The present invention refers to compositions comprising a LH-RH-analogue and/or pharmaceutical ly acceptable salts thereof in a low-dose and a degradation-resistant polylactide suitable for the preparation of subcutaneous implants. Sterilisation of the 5 polylactide via gamma-radiation as well as temperature stress result in a negligible decomposition of less than 1000 Dalton.